A turning point in therapy for ameloblastomas

Oral Oncol. 2018 May:80:95-96. doi: 10.1016/j.oraloncology.2018.03.007. Epub 2018 Mar 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Ameloblastoma / drug therapy*
  • Ameloblastoma / surgery
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Imidazoles / therapeutic use*
  • Jaw Neoplasms / drug therapy*
  • Jaw Neoplasms / surgery
  • Oximes / therapeutic use*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use*
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Oximes
  • Protein Kinase Inhibitors
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • dabrafenib